Page last updated: 2024-09-05

phosphatidylcholines and 2,3,4-tri-o-acetylarabinopyranosyl isothiocyanate

phosphatidylcholines has been researched along with 2,3,4-tri-o-acetylarabinopyranosyl isothiocyanate in 1 studies

Compound Research Comparison

Studies
(phosphatidylcholines)
Trials
(phosphatidylcholines)
Recent Studies (post-2010)
(phosphatidylcholines)
Studies
(2,3,4-tri-o-acetylarabinopyranosyl isothiocyanate)
Trials
(2,3,4-tri-o-acetylarabinopyranosyl isothiocyanate)
Recent Studies (post-2010) (2,3,4-tri-o-acetylarabinopyranosyl isothiocyanate)
32,2044435,59378262

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blum, R; Brack, A; Kloka, J; Martin, C; Mohammadi, M; Oehler, B; Rittner, HL1

Other Studies

1 other study(ies) available for phosphatidylcholines and 2,3,4-tri-o-acetylarabinopyranosyl isothiocyanate

ArticleYear
Antinociception by the anti-oxidized phospholipid antibody E06.
    British journal of pharmacology, 2018, Volume: 175, Issue:14

    Topics: Aldehydes; Analgesics; Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Autoantibodies; Capsaicin; Ganglia, Spinal; HEK293 Cells; Humans; Hyperalgesia; Irritants; Isothiocyanates; Male; Mice; Mice, Inbred C57BL; Neurons; Oxidation-Reduction; Pain; Phosphatidylcholines; Rats, Wistar; TRPA1 Cation Channel; TRPV Cation Channels

2018